Trials / Unknown
UnknownNCT05356637
Bipolar Sealer for Reduction of Blood Loss in Anterior Total Hip Arthroplasties
Prospective Trial of Bipolar Sealer for Reduction of Intra-Operative Blood Loss in Total Hip Arthroplasty Utilizing the Anterior Hip Approach
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- North Texas Medical Research Institute, PLLC · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The overall objectives and purpose of this study is to show that the Smith and Nephew Werewolf Fastseal 6.0 Bipolar Sealer is an effective tool to aide the surgical team in providing significant hemostasis during anterior total hip arthroplasty which would subsequently improve patient outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Werewolf Fastseal 6.0 | bi-polar hemostatic wand |
Timeline
- Start date
- 2022-04-29
- Primary completion
- 2024-01-31
- Completion
- 2024-02-01
- First posted
- 2022-05-02
- Last updated
- 2023-10-31
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05356637. Inclusion in this directory is not an endorsement.